Savara Stock (NASDAQ:SVRA), Quotes and News Summary

Q: What sector and industry does Savara (SVRA) operate in?

Savara is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Savara Stock (NASDAQ: SVRA) stock price, news, charts, stock research, profile.

Open	-
Close	-
Volume / Avg.	42.000 / 872.076K
Day Range	- - -
52 Wk Range	1.760 - 5.700
Market Cap	$649.296M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	44
Short Interest	3.33%
Days to Cover	7

Recent News

Rivian Automotive Reports Weak Delivery Figures, Joins JOYY, MiMedx Group And Other Big Stocks Moving Lower On Tuesday

U.S. stocks traded mostly lower, with the Nasdaq Composite falling around 200 points on Tuesday.

Avi Kapoor

5 OTC Stocks With The Potential To Explode In 2024

Investors who are ready to dive into the OTC pool have more options than ever, both with the number of stocks to choose from and available investing platforms.

Chris Bibey

Johnson & Johnson, Zions Bancorporation, Heritage-Crystal Clean And Other Big Stocks Moving Higher On Thursday

U.S. stocks traded mixed, with the Dow Jones gaining over 200 points on Thursday. Here are some big stocks recording gains in today’s session.

Lisa Levin

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trend

Nov 23

Feb

Mar

Apr

Buy

Hold

Sell

Strong Sell

Analyst Rating

4.1

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

About Savara Inc

Sector

Health Care

Industry

Biotechnology

Savara Inc is a biopharmaceutical company. It is focused on rare respiratory diseases. The company's...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Savara (SVRA) stock?

You can purchase shares of Savara (NASDAQ: SVRA) through any online brokerage.

View our list of the best stock brokerages.

Who are Savara's (SVRA) competitors?

Other companies in Savara’s space includes: Cabaletta Bio (NASDAQ:CABA), Cogent Biosciences (NASDAQ:COGT), Sage Therapeutics (NASDAQ:SAGE), Tango Therapeutics (NASDAQ:TNGX) and Pharming (NASDAQ:PHAR).

What is the target price for Savara (SVRA) stock?

The latest price target for Savara (NASDAQ: SVRA) was reported by JMP Securities on Friday, April 19, 2024. The analyst firm set a price target for 8.00 expecting SVRA to rise to within 12 months (a possible 70.21% upside). 9 analyst firms have reported ratings in the last year.

Current Stock Price for Savara (SVRA)?

The stock price for Savara (NASDAQ: SVRA) is $4.7 last updated April 22, 2024 at 4:00 PM EDT.

Does Savara (SVRA) pay a dividend?

There are no upcoming dividends for Savara.

When is Savara (NASDAQ:SVRA) reporting earnings?

Savara’s Q1 earnings are confirmed for Monday, May 13, 2024.

Is Savara (SVRA) going to split?

There is no upcoming split for Savara.

What sector and industry does Savara (SVRA) operate in?

Savara is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-